NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Fluidx Medical Technology

Fluidx Medical Technology

Private
Salt Lake City, UtahHealthcare & Life Scienceshttps://www.fluidxmedical.com/

Last Round

Series A

Extension

Mar 1, 2024

Est. Valuation

$32.16M

Total Funding Raised

$4.4M

Company Overview

Fluidx Medical Technology is a medical device company that develops innovative, controllable embolic gel technologies for peripheral vascular, interventional oncology, and neurovascular applications.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

embolic agentvascular embolizationinterventional radiologyliquid embolicmedical devicevascular surgeryperipheral vascularminimally invasiveembolicsinterventional medicineclinical trialsvascular occlusion

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Fluidx Medical Technology Comparables

Compare Fluidx Medical Technology with similar companies based on industry and business-model similarity.

Fluidx Medical Technology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Instylla
84%
Shape Memory Medical
82%
TripleMed
76%

Fluidx Medical Technology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionMar 1, 2024
Series A ExtensionApr 1, 2022
Series ASep 1, 2021
VC RoundMar 28, 2019

Key People

Founding team and executive leadership

Libble Ginster

President & CEO, Board Member

Executive Team

Fluidx Medical Technology Investors

Notable investors and investment history

Fluidx Medical Technology investors
InvestorRounds
MedMountain VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 3, 2026

    Monthly visitors increased 324% MoM, reaching 3K.

  • Sep 1, 2021

    $3M round led by Merit Medical Systems Inc.

Fluidx Medical Technology Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Fluidx Medical Technology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Fluidx Medical Technology's valuation, stock price, and market status.

Firmographic Details

HeadquartersSalt Lake City, Utah
Employee Range9
Year Founded2015
Last FundingMar 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.